• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年使用赛庚啶的超说明书用药:精神共病、相互作用变量、安全性及肝毒性风险

Off-Label Cyproheptadine in Children and Adolescents: Psychiatric Comorbidities, Interacting Variables, Safety, and Risks of Hepatotoxicity.

作者信息

Gupta Mayank, Gupta Nihit, Madabushi Jayakrishna

机构信息

Child and Adolescent Psychiatry, Southwood Psychiatric Hospital, Pittsburgh, USA.

Psychiatry, Dayton Children's Hospital, Dayton, USA.

出版信息

Cureus. 2023 Jan 13;15(1):e33745. doi: 10.7759/cureus.33745. eCollection 2023 Jan.

DOI:10.7759/cureus.33745
PMID:36788882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9922522/
Abstract

Cyproheptadine is a widely prescribed first-generation antihistamine, and due to its unique chemical structure, it has a popular off-label choice for a range of clinical conditions. Its efficacy is widely debated in the literature, but there are reports of hepatotoxicity as a rare adverse effect. Its benefits in migraine prophylaxis and appetite stimulation also underscore a highly overlapping clinical pathway that requires additional assessment and evaluation. The evidence suggests a baseline metabolic profile before initiation and assessment for co-occurring mental health conditions may improve overall response with evidence-based mental health interventions.

摘要

赛庚啶是一种广泛使用的第一代抗组胺药,由于其独特的化学结构,它在一系列临床病症中是一种常用的非标签用药选择。其疗效在文献中存在广泛争议,但有报告称肝毒性是一种罕见的不良反应。它在偏头痛预防和食欲刺激方面的益处也凸显了一条高度重叠的临床路径,这需要进行额外的评估和评价。有证据表明,在开始治疗前进行基线代谢评估以及对同时存在的心理健康状况进行评估,可能会通过基于证据的心理健康干预措施改善总体反应。

相似文献

1
Off-Label Cyproheptadine in Children and Adolescents: Psychiatric Comorbidities, Interacting Variables, Safety, and Risks of Hepatotoxicity.儿童和青少年使用赛庚啶的超说明书用药:精神共病、相互作用变量、安全性及肝毒性风险
Cureus. 2023 Jan 13;15(1):e33745. doi: 10.7759/cureus.33745. eCollection 2023 Jan.
2
Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review.食欲素药物赛庚啶的安全性。法国国家药物警戒数据库分析及系统评价
Front Pediatr. 2021 Sep 29;9:712413. doi: 10.3389/fped.2021.712413. eCollection 2021.
3
Prophylactic treatment of pediatric migraine.儿童偏头痛的预防性治疗。
Headache. 2004 Mar;44(3):230-7. doi: 10.1111/j.1526-4610.2004.04052.x.
4
[Action of cyproheptadine (periactin) on appetite stimulation in children. Study of 40 cases].[赛庚啶(periactin)对儿童食欲刺激的作用。40例研究]
Schweiz Rundsch Med Prax. 1973 Jun 19;62(25):798-801.
5
Comparison of a new antihistamine HC 20-511 with cyproheptadine (Periactin) in chronic urticaria.一种新型抗组胺药HC 20 - 511与赛庚啶(periactin)治疗慢性荨麻疹的比较。
Acta Allergol. 1977 Oct;32(5):316-20. doi: 10.1111/j.1398-9995.1977.tb02573.x.
6
Efficacy and Tolerability of Cyproheptadine in Poor Appetite: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.赛庚啶治疗食欲减退的疗效与耐受性:一项多中心、随机、双盲、安慰剂对照研究。
Clin Ther. 2021 Oct;43(10):1757-1772. doi: 10.1016/j.clinthera.2021.08.001. Epub 2021 Sep 8.
7
Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children.赛庚啶治疗儿童消化不良症状的安全性和有效性。
J Pediatr. 2013 Jul;163(1):261-7. doi: 10.1016/j.jpeds.2012.12.096. Epub 2013 Feb 16.
8
BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents.英国精神药理学会立场声明:向儿童和青少年开具精神药物的超说明书用药
J Psychopharmacol. 2016 May;30(5):416-21. doi: 10.1177/0269881116636107.
9
Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.丙戊酸镁缓释片用于青少年偏头痛预防:一项独立长期开放标签安全性研究的结果
Headache. 2009 Jan;49(1):45-53. doi: 10.1111/j.1526-4610.2008.01279.x. Epub 2008 Nov 14.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

本文引用的文献

1
Attention deficit hyperactivity disorder and risk of migraine: A nationwide longitudinal study.注意缺陷多动障碍与偏头痛风险:一项全国性纵向研究。
Headache. 2022 May;62(5):634-641. doi: 10.1111/head.14306. Epub 2022 May 6.
2
The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies.头痛与情感障碍之间的双向时间关系:来自 HUNT 研究的纵向数据。
J Headache Pain. 2022 Jan 21;23(1):14. doi: 10.1186/s10194-022-01388-x.
3
Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review.食欲素药物赛庚啶的安全性。法国国家药物警戒数据库分析及系统评价
Front Pediatr. 2021 Sep 29;9:712413. doi: 10.3389/fped.2021.712413. eCollection 2021.
4
Efficacy and Tolerability of Cyproheptadine in Poor Appetite: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.赛庚啶治疗食欲减退的疗效与耐受性:一项多中心、随机、双盲、安慰剂对照研究。
Clin Ther. 2021 Oct;43(10):1757-1772. doi: 10.1016/j.clinthera.2021.08.001. Epub 2021 Sep 8.
5
Mirtazapine Improved Eating Patterns in Avoidant/Restrictive Food Intake Disorder.米氮平改善了回避/限制性食物摄入障碍患者的饮食模式。
Am J Ther. 2023;30(2):173-175. doi: 10.1097/MJT.0000000000001338. Epub 2021 Jan 20.
6
Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine.两例安非他酮过量致血清素综合征患者用赛庚啶治疗。
J Emerg Med. 2021 Apr;60(4):e67-e71. doi: 10.1016/j.jemermed.2020.10.039. Epub 2020 Dec 8.
7
The Law and Practice of Off-Label Prescribing and Physician Promotion.《药品说明书外使用及医师推广的法律与实践》
J Am Acad Psychiatry Law. 2021 Mar;49(1):53-59. doi: 10.29158/JAAPL.200049-20. Epub 2020 Nov 24.
8
Autism and Migraine: An Unexplored Association?自闭症与偏头痛:一种未被探索的关联?
Brain Sci. 2020 Sep 6;10(9):615. doi: 10.3390/brainsci10090615.
9
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT Receptor Antagonists.抗精神病药所致静坐不能的治疗:5-羟色胺 5-HT 受体拮抗剂的作用。
Drugs. 2020 Jun;80(9):871-882. doi: 10.1007/s40265-020-01312-0.
10
Use of Cyproheptadine for the Treatment of Serotonin Syndrome: A Case Series.赛庚啶治疗血清素综合征:病例系列
J Clin Psychopharmacol. 2020 Jan/Feb;40(1):95-99. doi: 10.1097/JCP.0000000000001159.